149 related articles for article (PubMed ID: 1493854)
1. TGF-beta 3 protects normal human hematopoietic progenitor cells treated with 4-hydroperoxycyclophosphamide in vitro.
Lemoli RM; Strife A; Clarkson BD; Haley JD; Gulati SC
Exp Hematol; 1992 Dec; 20(11):1252-6. PubMed ID: 1493854
[TBL] [Abstract][Full Text] [Related]
2. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
[TBL] [Abstract][Full Text] [Related]
3. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
Lemoli RM; Gulati SC
Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
9. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
[TBL] [Abstract][Full Text] [Related]
10. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
[TBL] [Abstract][Full Text] [Related]
11. Photoradiation methods for purging autologous bone marrow grafts.
Gulati S; Atzpodien J; Lemoli RM; Shimazaki C; Clarkson B
Prog Clin Biol Res; 1990; 333():87-102. PubMed ID: 2137934
[TBL] [Abstract][Full Text] [Related]
12. Survival of highly proliferative colony forming cells after treatment of bone marrow cells with 4-hydroperoxycyclophosphamide.
Komatsu N; Suda T; Suda J; Miura Y
Cancer Res; 1987 Dec; 47(23):6371-6. PubMed ID: 3677081
[TBL] [Abstract][Full Text] [Related]
13. Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells.
Ottmann OG; Pelus LM
J Immunol; 1988 Apr; 140(8):2661-5. PubMed ID: 3258618
[TBL] [Abstract][Full Text] [Related]
14. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N
Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
[TBL] [Abstract][Full Text] [Related]
15. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W
Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914
[TBL] [Abstract][Full Text] [Related]
16. Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor cells from 4-hydroperoxycyclophosphamide by interleukin 1 beta and tumor necrosis factor.
Moreb J; Zucali JR; Zhang Y; Colvin MO; Gross MA
Cancer Res; 1992 Apr; 52(7):1770-4. PubMed ID: 1551107
[TBL] [Abstract][Full Text] [Related]
17. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
19. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
Grant S; Bhalla K; Arlin Z; Howe CW
Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta: possible roles in the regulation of normal and leukemic hematopoietic cell growth.
Keller JR; Sing GK; Ellingsworth LR; Ruscetti FW
J Cell Biochem; 1989 Feb; 39(2):175-84. PubMed ID: 2654150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
